Divar (website)

Iranian classified advertising platform From Wikipedia, the free encyclopedia

Divar (website)

Divar (Persian: دیوار; lit. "wall") is an Iranian Persian classified ads and E-commerce mobile app, and an online platform for users in Iran[1] founded in Iran in 2012 with sections devoted to real estate, vehicles, goods, community service, Industrial equipment and jobs.[2] On average, Divar’s users post more than 139.7 million new ads & over 53.1 million users open the app annually based on the latest published annual report. [3] [4]

Quick Facts Type of business, Type of site ...
Divar
Thumb
Screenshot of the user interface buttons and place of ads in the app
Type of businessPrivate web communications
Type of site
Digital advertising
Available inFarsi(Persian)
Founded2012
Country of originIran
No. of locationsSaadat Abad, Tehran, Tehran 1997748311, IR
IndustryClassifieds
Employees501-1,000
ParentAgah pardazan hooshmand
URLdivar.ir
IPv6 supportYes
CommercialYes
RegistrationYes
Current statusActive
Native client(s) oniOS, Android, PWA
Written inJavaScript, Python, Java, C++
Close

Ads

To use this app, users must register, have a valid National Iranian ID number, and they must pay for posting more than 3 ads.

Control and censor

The website periodically censors prices of cars, house rental, and real estate. This program has put 3500 words in its black list, if the user uses these words, the user's chat or post will be blocked.[5] Masseuse/massage ads are censored and deleted.[6]

Features

  • Night Mode
  • Supports screen reader
  • Accessibility[7]

Foreign investment

One Dutch company has invested $47 million in the company.[8]

Service

The app sorts ads by Iranian cities, districts, and categories

  • Real estate
  • Vehicles
  • Electronics
  • Home
  • Services
  • Personal
  • Entertainment and leisure
  • Social
  • Business
  • Job hiring and employment

Award

Iran web and mobile festival – best accessibility features[9]

See also

References

Wikiwand - on

Seamless Wikipedia browsing. On steroids.